Virological response after 6 week triple-drug regimens for hepatitis C: A proof-of-concept phase 2A cohort study

Anita Kohli, Anuoluwapo Osinusi, Zayani Sims, Amy Nelson, Eric G. Meissner, Lisa L. Barrett, Dimitra Bon, Miriam M. Marti, Rachel Silk, Colleen Kotb, Chloe Gross, Tim A. Jolley, Sreetha Sidharthan, Tess Petersen, Kerry Townsend, D'Andrea Egerson, Rama Kapoor, Emily Spurlin, Michael Sneller, Michael ProschanEva Herrmann, Richard Kwan, Gebeyehu Teferi, Rohit Talwani, Gabbie Diaz, David E. Kleiner, Brad J. Wood, Jose Chavez, Stephen Abbott, William T. Symonds, G. Mani Subramanian, Phillip S. Pang, John McHutchison, Michael A. Polis, Anthony S. Fauci, Henry Masur, Shyam Kottilil

Research output: Contribution to journalArticlepeer-review

123 Scopus citations

Fingerprint

Dive into the research topics of 'Virological response after 6 week triple-drug regimens for hepatitis C: A proof-of-concept phase 2A cohort study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases